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Methods: We studied glucose levels and glycosylated hemoglobin in 91 consecutive patients with acute stroke admitted within 24 hours after onset of symptoms. In 27 unselected patients we also measured catecholamines on days 1 and 3 after onset.
Results: Hyperglycemia was found in 39 (43%) of the patients, 55% of whom either had diabetes mellitus or latent diabetes; the others had idiopathic hyperglycemia. Norepinephrine levels were associated with the severity of the stroke (P=.005) and with hypertension (P=.03) but not with glucose levels, irrespective of whether or not the patients had diabetes. 
Conclusions

Results
The mean±SD age of the 91 patients was 66.7±13.2 years; 52 were male and 39 female. Twelve (13%) patients had had a transient ischemic attack, 63 (69%) an ischemic stroke, and 16 (18%) a primary intracerebral hemorrhage. Random blood glucose levels on admission were measured in 76 patients, a fasting glucose was measured in 80 patients, and in 65 patients both random and fasting glucose levels were obtained. Hyperglycemia was found in 39 (43%) of the 91 patients. None of the patients with hyperglycemia had received glucose infusions during the first days after admission.
HbAlC levels were measured in 88 patients. All 10 patients with a history of diabetes had increased HbAlc.
Of the other 29 hyperglycemic patients, 12 also had elevated HbA,, levels, and these patients were considered latent diabetics. The remaining 17 patients had idiopathic hyperglycemia. Seventeen patients with elevated HbAl, levels had normal glucose levels. The baseline characteristics of patients with diabetes, idiopathic hyperglycemia, and normal glucose levels are summarized in Table 2 . Stroke outcome at 3 months was significantly better in the patients with normoglycemia (P=.047). No significant differences in any of the baseline characteristics between hyperglycemic and normoglycemic patients were found in either the univariate analysis or the multivariate analysis.
Catecholamines were measured in 5 patients with transient ischemic attack, 19 with an ischemic stroke, and 3 with a primary intracerebral bleeding. There was no significant difference in baseline characteristics between these patients and the others of the study population. Mean+SD values of norepinephrine and epinephrine on days 1 and 3 for each subgroup are shown in the Figure. No significant association was found between catecholamine levels and blood glucose, HbAl,, and stroke subtype in either the total population or any of the four subgroups. Patients with idiopathic hyperglycemia had significantly lower levels of epinephrine on day 3 than normoglycemic patients (P=.013). Patients with more severe strokes had significantly higher levels of norepinephrine (P=.005). Hypertension was significantly associated with norepinephrine (P=.03) and epinephrine (P=.04).
Discussion
In this study, we have found that 43% of patients with acute stroke had hyperglycemia. More than half of these patients had known or latent diabetes mellitus; in the others the cause of hyperglycemia was unknown. We found a significant association between hyperglycemia and stroke outcome, but not between hyperglycemia and stroke severity at onset. In addition, a significant association was found between norepinephrine levels and stroke severity on admission. However, a significant relation between catecholamine and glucose level, irrespective of whether or not the patients had diabetes, could not be shown. In comparison with normoglycemic patients, those with idiopathic hyperglycemia had lower levels of epinephrine on day 3 and did not have more severe strokes. These findings demonstrate that the increased glucose in the nondiabetic patients cannot be explained by stress. In addition, the relatively higher levels of norepinephrine than epinephrine provide an argument against significant adrenal activation as part of a generalized stress response.9 van (40) 3 (8) 29 (74) 7 (18) 18 (46) 11 (28) 3 (3) 23 (59) 16 (41) 9(17) 34 (66) 9 (17) 29 (55) 11 (21) 3 (5) 22 (42) 
